93M1 — MPH Health Care AGFinancial Services · Asset ManagementXETR
€92.0M
Mkt Cap
€101.6M
Ent. Value
-€9.5M
Net Cash
€21.50
52W €16 – €29
€92.0M
Mkt Cap
€101.6M
Ent. Value
-€9.5M
Net Cash
N/M
P/E TTM
—
PEG
—
P/FCF
0.3×
P/Book
15.1×
P/Sales
3.0×
EV/EBITDA
3.1×
EV/EBIT
55.6×
EV/FCF
16.6×
EV/Sales
-127.6%
Earn Yld
—
FCF Yld
5.6%
Div Yld
€21.50
·
All values in Euros (EUR)
EUR
FY2024
FY2023
FY2022
FY2021
Revenue
6.11M
6.25M
6.61M
3.56M
YoY Growth
-2.2%
-5.4%
+85.5%
—
Gross Profit
—
—
—
—
Gross Margin
—
—
—
—
R&D
—
—
—
—
SG&A
1.14M
1.14M
987,246
923,321
EBIT
32.96M
30.21M
29.38M
(9.49M)
EBIT Margin
539.3%
483.5%
444.7%
-266.5%
D&A
27,659
19,109
25,169
20,077
EBITDA
33.32M
30.36M
29.67M
(8.97M)
EBITDA Margin
545.2%
486.0%
449.2%
-252.0%
Net Income
32.04M
29.54M
29.11M
(8.96M)
Net Margin
524.3%
472.9%
440.8%
-251.5%
EPS (diluted)
€7.48
€6.90
€6.80
-€2.09
Shares (dil., M)
4
4
4
4
Company Brief
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It operates through Beauty, Pharma, and Real Estate segments. The company offers medical-aesthetic beauty surgeries and treatments, as well as operation and provision of medical infrastructures for partner companies; and sells pharmaceuticals and medical products in the areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. It also provides plastic and aesthetic treatments and surgeries; operates European mail-order pharmacy. In addition, the company is involved in real estate business; acts as an investment manager; renewable energies; and project development, including new residential construction/owner occupied homes. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was incorporated in 2008 and is based in Berlin, Germany.
CEOMr. Patrick BrenskeEmployees2IPO Date2011-05-16CountryGermanyWebsitewww.mph-ag.de
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It operates through Beauty, Pharma, and Real Estate segments. The company offers medical-aesthetic beauty surgeries and treatments, as well as operation and provision of medical infrastructures for partner companies; and sells pharmaceuticals and medical products in the areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. It also provides plastic and aesthetic treatments and surgeries; operates European mail-order pharmacy. In addition, the company is involved in real estate business; acts as an investment manager; renewable energies; and project development, including new residential construction/owner occupied homes. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was incorporated in 2008 and is based in Berlin, Germany.
CEOMr. Patrick BrenskeEmployees2IPO Date2011-05-16CountryGermanyWebsitewww.mph-ag.de
